Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 33.3 M29.6 M24 M26.4 M26.6 M27 M 104 M Research & development —————— — Operating income 500 K-3.1 M15.9 M12 M36.6 M56 M 120.5 M Non-Operating Income, Total 2.5 M-1.1 M-5.6 M1.3 M-2.1 M5.7 M -700 K Interest expense, net of interest capitalized 16.9 M18 M16.3 M17.3 M18.1 M17.9 M 69.6 M Non-Operating Income, excl. Interest Expenses -11.3 M-17.7 M-24.4 M-13.7 M-19.9 M-11.7 M -69.7 M Unusual income/expense -3.1 M-1.4 M2.5 M-2.3 M-300 K-500 K -600 K Pretax income -13.9 M-22.2 M-13.6 M-4 M16.4 M28.7 M 27.5 M Equity in earnings ———0—— — Taxes 9.7 M9.8 M3.4 M3.2 M-2.2 M16 M 20.4 M Non-controlling/minority interest —————— — After tax other income/expense 900 K-1.5 M-700 K1.9 M-1.7 M-200 K -700 K Net income before discontinued operations -23.6 M-32 M-17 M-7.2 M18.6 M12.7 M 7.1 M Discontinued operations —————— — Net income -23.6 M-32 M-17 M-7.2 M18.6 M12.7 M 7.1 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -23.6 M-32 M-17 M-7.2 M18.3 M12.5 M 6.6 M Basic earnings per share (Basic EPS) -0.57-0.77-0.41—0.430.3 — Diluted earnings per share (Diluted EPS) -0.57-0.77-0.41-0.170.430.3 0.15 Average basic shares outstanding 41.44 M41.52 M41.86 M41.83 M42.08 M42.16 M — Diluted shares outstanding 41.44 M41.52 M41.86 M41.83 M42.27 M42.36 M — EBITDA 300.7 M446.4 M228.4 M241.3 M395.9 M466.3 M 1.33 B EBIT 273.9 M419.9 M205.2 M214.6 M369.5 M438.1 M 1.23 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 26.8 M26.5 M23.2 M26.7 M26.4 M28.2 M 104.5 M